DC Funds, LP — Q4 2023 13F-HR

← DC Funds, LP

Q4 2023 · 13F-HR

DC Funds, LPholdings as filed

Filed 2024-02-13 · accession 0001398344-24-002804

$8.3M

Reported value

Positions

2023-12-31

Period end

View analyzed profile →PRO

Holdings as filed

CUSIP	Ticker	Issuer	Value	% port.	Shares	Class	Voting
89854M101	TCRX	TSCAN THERAPEUTICS INC	$3.7M	44.2%	630,000	Common	SOLE
91864C107	BRNS	BARINTHUS BIOTHERAPEUTICS PL	$2.4M	28.5%	642,204	Common	SOLE
95075A107	HOWL	WEREWOLF THERAPEUTICS INC	$2.3M	27.3%	589,102	Common	SOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.